| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,¶
* Department of Pharmacology, School of Pharmacy, Faculty of Medicine, and
Lautenberg Center for General and Tumor Immunology, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem Israel;
Department of Pharmacology, University of Bern, Bern, Switzerland;
Istituto Giannina Gaslini, Genova, Italy;
¶ Department of Experimental Medicine, University of Genova, Genova, Italy;
|| Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63105
Eosinophils are present in parasitic, allergic, various immunological, and malignant disorders as well as in a variety of idiopathic hypereosinophilic syndromes. However, their exact role in some of these conditions remains elusive. They can be activated both in vivo and in vitro by various agonists, such as Igs, lipid mediators, and cytokines. By phenotyping the surface of the eosinophils, it may be possible to better define their function(s) in different pathophysiological settings. In the present work we screened eosinophils with a panel of Abs recognizing CD2 subfamily receptors usually present on a number of hemopoietic cells. We have demonstrated that human peripheral blood eosinophils, but not basophils or neutrophils, express NTB-A. In addition eosinophils express 2B4, CD84, CD58, and CD48, but not signaling lymphocytic activation molecule or CD2, on their surface (FACS). Cross-linking of 2B4 on eosinophils elicited a significant release of eosinophil peroxidase (30 min), IFN-
, and IL-4 (18 h). Moreover, activation of eosinophils via 2B4 induced eosinophil-mediated cytotoxicity toward two malignant cell lines, i.e., mouse mastocytoma P815 and EBV-infected 721.221 B cell lines. Cross-linking of 2B4 on the surface of eosinophils or pervenadate treatment elicited ERK and tyrosine phosphorylation, respectively. Furthermore, we showed that eosinophils express slam-associated protein. The demonstration that human eosinophils express a functional 2B4 receptor indicates a broader role for these cells in health and disease.
This article has been cited by other articles:
|
|
 |
|
  I. Bachelet, A. Munitz, D. Mankutad, and F. Levi-Schaffer Mast Cell Costimulation by CD226/CD112 (DNAM-1/Nectin-2): A NOVEL INTERFACE IN THE ALLERGIC PROCESS J. Biol. Chem., September 15, 2006; 281(37): 27190 - 27196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Eissmann and C. Watzl Molecular Analysis of NTB-A Signaling: A Role for EAT-2 in NTB-A-Mediated Activation of Human NK Cells. J. Immunol., September 1, 2006; 177(5): 3170 - 3177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Munitz, I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils J. Immunol., July 1, 2006; 177(1): 77 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Messmer, P. Eissmann, S. Stark, and C. Watzl CD48 Stimulation by 2B4 (CD244)-Expressing Targets Activates Human NK Cells. J. Immunol., April 15, 2006; 176(8): 4646 - 4650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bhat, P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl Fine-tuning of immune responses by SLAM-related receptors J. Leukoc. Biol., March 1, 2006; 79(3): 417 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Munitz, I. Bachelet, R. Eliashar, A. Moretta, L. Moretta, and F. Levi-Schaffer The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils Blood, March 1, 2006; 107(5): 1996 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Berent-Maoz, A. M. Piliponsky, I. Daigle, H.-U. Simon, and F. Levi-Schaffer Human Mast Cells Undergo TRAIL-Induced Apoptosis J. Immunol., February 15, 2006; 176(4): 2272 - 2278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Assarsson, T. Kambayashi, C. M. Persson, B. J. Chambers, and H.-G. Ljunggren 2B4/CD48-Mediated Regulation of Lymphocyte Activation and Function J. Immunol., August 15, 2005; 175(4): 2045 - 2049. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
